Nicola J Hall1, Greg P Rubin1, Christina Dobson1, David Weller2, Jane Wardle3, Mary Ritchie4, Colin J Rees5. 1. School of Medicine, Pharmacy and Health, Durham University, Stockton on Tees, UK. 2. Cancer Research Centre, University of Edinburgh, Edinburgh, UK. 3. Health Behaviour Research Centre, University College London, London, UK. 4. South of Tyne NHS Bowel Cancer Screening Centre, Gateshead, UK. 5. South Tyneside NHS Foundation Trust, South Shields, UK.
Abstract
BACKGROUND: Uptake of colorectal cancer screening programmes needs to be improved or at least maintained in order to achieve projected reductions in mortality and morbidity. Understanding the origins of non-participation in screening is therefore important. OBJECTIVE: To explore the beliefs and experiences of individuals who had not responded either to their screening invitation or reminder. DESIGN: A qualitative study using in-depth interviews with non-participants from England's population-based colorectal cancer screening programme. Data collection and analysis were carried out using a grounded theory approach, with an emphasis on the constant comparison method, and continued until saturation (27 interviews). FINDINGS: The interviews provided an in-depth understanding of a range of reasons and circumstances surrounding non-participation in screening, including contextual and environmental influences as well as factors specific to the screening test. Non-participation in screening was not necessarily associated with negative attitudes towards screening or a decision to not return a kit. Reasons for non-participation in screening included not feeling that participation is personally necessary, avoiding or delaying decision making, and having some degree of intention to take part but failing to do so because of practicalities, conflicting priorities or external circumstances. Beliefs, awareness and intention change over time. DISCUSSION AND CONCLUSIONS: A range of approaches may be required to improve screening uptake. Some non-participants may already have a degree of intention to take part in screening in the future, and this group may be more responsive to interventions based on professional endorsement, repeat invitations, reminders and aids to making the test more practical.
BACKGROUND: Uptake of colorectal cancer screening programmes needs to be improved or at least maintained in order to achieve projected reductions in mortality and morbidity. Understanding the origins of non-participation in screening is therefore important. OBJECTIVE: To explore the beliefs and experiences of individuals who had not responded either to their screening invitation or reminder. DESIGN: A qualitative study using in-depth interviews with non-participants from England's population-based colorectal cancer screening programme. Data collection and analysis were carried out using a grounded theory approach, with an emphasis on the constant comparison method, and continued until saturation (27 interviews). FINDINGS: The interviews provided an in-depth understanding of a range of reasons and circumstances surrounding non-participation in screening, including contextual and environmental influences as well as factors specific to the screening test. Non-participation in screening was not necessarily associated with negative attitudes towards screening or a decision to not return a kit. Reasons for non-participation in screening included not feeling that participation is personally necessary, avoiding or delaying decision making, and having some degree of intention to take part but failing to do so because of practicalities, conflicting priorities or external circumstances. Beliefs, awareness and intention change over time. DISCUSSION AND CONCLUSIONS: A range of approaches may be required to improve screening uptake. Some non-participants may already have a degree of intention to take part in screening in the future, and this group may be more responsive to interventions based on professional endorsement, repeat invitations, reminders and aids to making the test more practical.
Authors: R Hiatt; J Wardle; S Vernon; J Austoker; L Bistanti; S Fox; R Gnauck; D Iverson; M Mandelson; D Reading; R Smith Journal: Ann Oncol Date: 2005-01 Impact factor: 32.976
Authors: Randa Sifri; Michael Rosenthal; Terry Hyslop; Jocelyn Andrel; Richard Wender; Sally W Vernon; James Cocroft; Ronald E Myers Journal: Prev Med Date: 2010-06-25 Impact factor: 4.018
Authors: Leo G van Rossum; Anne F van Rijn; Robert J Laheij; Martijn G van Oijen; Paul Fockens; Han H van Krieken; Andre L Verbeek; Jan B Jansen; Evelien Dekker Journal: Gastroenterology Date: 2008-03-25 Impact factor: 22.682
Authors: Tony Antoniou; Nathaniel Jembere; Refik Saskin; Alexander Kopp; Richard H Glazier Journal: BMC Health Serv Res Date: 2015-02-01 Impact factor: 2.655
Authors: Sally C Benton; Piers Butler; Katy Allen; Michelle Chesters; Sally Rickard; Sally Stanley; Richard Roope; Daniel Vulkan; Stephen W Duffy Journal: Br J Cancer Date: 2017-05-18 Impact factor: 7.640
Authors: Jason Liwen Huang; Yuan Fang; Miaoyin Liang; Shannon Ts Li; Simpson Kc Ng; Zero Sn Hui; Jessica Ching; Harry Haoxiang Wang; Martin Chi Sang Wong Journal: AIMS Public Health Date: 2017-06-22